Biochemist's work helps new company focus on potential hepatitis B cure
Wednesday, July 16, 2014 - 07:05
in Health & Medicine
An Indiana University biochemist's discovery of a class of anti-viral small molecules that target the function of a virus DNA hidden in the infected livers of hepatitis B patients may lead to a cure for this viral infection that kills more than 600,000 people annually.